THE PROGNOSTIC SIGNIFICANCE OF P53, BCL2 AND MIB1 EXPRESSIONS RELATED WITH OTHER CLINICOPATHOLOGICAL VARIABLES IN SEROUS OVARIAN CARCINOMAS. A CLINICOPATHOLOGICAL STUDY IN PERITONEAL FLUIDS.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 26204652
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ovarian Cancer: Diagnostic, Biological and Prognostic Aspects

  2014cited by this paper
• Natural history of ovarian cancer

  2014cited by this paper
• Investigating Molecular Profiles of Ovarian Cancer: An Update on Cancer Stem Cells

  2014cited by this paper
• New Hypothesis on Pathogenesis of Ovarian Cancer Lead to Future Tailored Approaches

  2013cited by this paper
• Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

  2012cited by this paper
• Apoptosis and cell proliferation correlated with tumour grade in peritoneal fluids of patients with serous ovarian cancer

  2011cited by this paper
• Molecular Characterization of 103 Ovarian Serous and Mucinous Tumors

  2011cited by this paper
• Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.

  2011cited by this paper
• An Immunohistochemical Comparison of P53 and Bcl-2 as Apoptotic and MIB1 as Proliferative Markers in Low-Grade and High-Grade Ovarian Serous Carcinomas

  2010cited by this paper
• P53, bcl-2, ki-67 li (labeling index) status in benign, proliferative, and malignant ovarian surface epithelial neoplasms.

  2009cited by this paper
• Ovarian cancer : state of the art and future directions in translational research

  2008cited by this paper
• Apoptosis in epithelial ovarian tumors.

  2002cited by this paper
• P53, bcl-2, and bax: Their relationship and effect on prognosis in early stage epithelial ovarian carcinoma

  2001cited by this paper
• bcl-2, bax, bcl-XL, and bcl-XS expression in normal and neoplastic ovarian tissues.

  1998cited by this paper
• Expression and localization of Bcl-2 related proteins in human ovarian cancers.

  1998cited by this paper
• Mechanisms of apoptotic cell death

  1997cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.

  1997cited by this paper
• The combined evaluation of p53 accumulation and of Ki-67 (MIB1) labelling index provides independent information on overall survival of ovarian carcinoma patients.

  1997influential reference
• bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.

  1996cited by this paper
• Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?

  1995cited by this paper
• Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.

  1995cited by this paper
• Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma

  1995cited by this paper
• Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

  1994cited by this paper
• p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry.

  1994cited by this paper
• p53 mutation is a common genetic event in ovarian carcinoma.

  1993cited by this paper
• p53 accumulation in ovarian carcinomas and its prognostic implications.

  1993cited by this paper
• Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections

  1992influential reference
• Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.

  1991cited by this paper
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

  1990cited by this paper

• Role of WT1, B-cell lymphoma 2, Ki-67 (Mib1), and Her2/Neu as diagnostic and prognostic immunomarkers in ovarian serous and endometroid carcinoma

  2021cites this paper
• Up-regulation of GSTT1 in serous ovarian cancer associated with resistance to TAXOL / carboplatin

  2021cites this paper
• Calcineurin Gamma Catalytic Subunit PPP3CC Inhibition by miR-200c-3p Affects Apoptosis in Epithelial Ovarian Cancer

  2021cites this paper
• Importancia de la temperatura de la quimioterapia intraperitoneal intraoperatoria con paclitaxel en el tratamiento quirúrgico radical de la carcinomatosis peritoneal de origen ovárico. Hipertermia versus normotermia

  2017cites this paper